Results of long-term follow-up for patients with advanced gastrointestinal stromal tumor underwent palliative surgery after tyrosine kinase inhibitors therapy.
Haibo Qiu(Zhongda Hospital Southeast University), Zhiwei Zhou(Sun Yat-sen University), Yuanxiang Guan(Sun Yat-sen University), Xingyu Feng(Guangdong General Hospital), Yuanfang Li(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Xiaowei Sun(Affiliated Zhongshan Hospital of Dalian University), Youqing Zhan(Sun Yat-sen University), Zhongguo Zhou(Sun Yat-sen University), Dazhi Xu(Fudan University Shanghai Cancer Center), Yingbo Chen(Sun Yat-sen University Cancer Center), Wei Li(University of California, Irvine)
Cited by 1
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868